Patent details

EP1105109 Title: INJECTABLE FORMULATIONS OF NANOPARTICULATE NAPROXEN

Basic Information

Publication number:
EP1105109
PCT Application Number:
PCT/US/99/18270
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP999410657
PCT Publication Number:
WO/00/00909
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INJECTABLE FORMULATIONS OF NANOPARTICULATE NAPROXEN
French Title of Invention:
FORMULATIONS INJECTABLES DE NANOPARTICULES DE NAPROXENE
German Title of Invention:
INJEKTIERBARE FORMULIERUNGEN MIT NANOPARTIKULÄREM NAPROXEN
SPC Number:

Dates

Filing date:
12/08/1999
Grant date:
23/04/2003
EP Publication Date:
23/04/2003
PCT Publication Date:
24/02/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/06/2001
EP B1 Publication Date:
23/04/2003
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/08/2003
Expiration date:
12/08/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/08/1999
 
 

Name:
Elan Pharma International Limited
Address:
WIL House, Shannon Business Park, Shannon, Clare County, Ireland (IE)

Inventor

1

Name:
LEE Robert
Address:
United States (US)

2

Name:
DE CASTRO Lan
Address:
United States (US)

Priority

Priority Number:
154422
Priority Date:
13/08/1998
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/51;
Filing date Document type Number of pages